LumiraDx Ltd (LMDXF)
0.025
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
LumiraDx Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 354.87M |
| May 02, 2024 | 353.67M |
| May 01, 2024 | 351.99M |
| April 30, 2024 | 354.23M |
| April 29, 2024 | 351.83M |
| April 26, 2024 | 352.31M |
| April 25, 2024 | 351.79M |
| April 24, 2024 | 352.31M |
| April 23, 2024 | 351.67M |
| April 22, 2024 | 352.07M |
| April 19, 2024 | 353.27M |
| April 18, 2024 | 353.37M |
| April 17, 2024 | 355.22M |
| April 16, 2024 | 354.87M |
| April 15, 2024 | 352.92M |
| April 12, 2024 | 351.67M |
| April 11, 2024 | 350.72M |
| April 10, 2024 | 350.05M |
| April 09, 2024 | 349.92M |
| April 08, 2024 | 349.73M |
| April 05, 2024 | 349.38M |
| April 04, 2024 | 349.63M |
| April 03, 2024 | 349.73M |
| April 02, 2024 | 349.28M |
| April 01, 2024 | 349.28M |
| Date | Value |
|---|---|
| March 28, 2024 | 349.31M |
| March 27, 2024 | 349.31M |
| March 26, 2024 | 349.63M |
| March 25, 2024 | 349.54M |
| March 22, 2024 | 349.54M |
| March 21, 2024 | 349.57M |
| March 20, 2024 | 349.50M |
| March 19, 2024 | 349.62M |
| March 18, 2024 | 349.63M |
| March 15, 2024 | 349.76M |
| March 14, 2024 | 349.70M |
| March 13, 2024 | 349.76M |
| March 12, 2024 | 349.74M |
| March 11, 2024 | 349.66M |
| March 08, 2024 | 349.76M |
| March 07, 2024 | 349.66M |
| March 06, 2024 | 349.80M |
| March 05, 2024 | 349.79M |
| March 04, 2024 | 349.82M |
| March 01, 2024 | 349.70M |
| February 29, 2024 | 349.70M |
| February 28, 2024 | 349.73M |
| February 27, 2024 | 349.63M |
| February 26, 2024 | 349.85M |
| February 23, 2024 | 350.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
349.28M
Minimum
Apr 01 2024
2.745B
Maximum
Nov 17 2021
914.02M
Average
549.78M
Median
Jan 03 2023
Enterprise Value Benchmarks
| RadNet Inc | 4.444B |
| DermTech Inc | -33.87M |
| Centogene NV | -- |
| iSpecimen Inc | -2.616M |
| 23andMe Holding Co | 0.151M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -49.74M |
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 69.43M |
| EPS Diluted (Quarterly) | -0.15 |
| Gross Profit Margin (Quarterly) | -47.14% |
| Profit Margin (Quarterly) | -236.8% |